No Data
Unmissable investment strategy! The Federal Reserve officially enters a new era of interest rate cuts, these 6 industries have the most profitable potential.
Prepare yourself for the interest rate cut cycle.
Two major heavyweight events, "interest rate cuts + elections", have struck suddenly! Can the US stock market break the century-old curse of "September Hex"?
Since 1990, the average September decline of the S&P 500 index is 1.04%, with only a 47% chance of closing higher, performing far worse than other months.
EXCLUSIVE: Beyond The Magnificent Seven — Direxion's Egilinsky Reveals Top Sector Picks
The global interest rate cut cycle may start! Medical stocks in the US stock market are ready to explode. How to accurately capture the opportunity for skyrocketing?
AbbVie, AstraZeneca, Eli Lilly and Co, Intuitive Surgical, Novartis AG, and other pharmaceutical giants, as well as the robotic surgery giant Intuitive Surgical, have all reached record highs this year, with growth ranging from 18% to 64%, and even surpassing other technology giants except Nvidia.
Investment guide is here! With the Fed's interest rate cut imminent, which ETFs are expected to benefit?
From historical data, the certainty of US bonds rising in the early stages of interest rate cuts is very high. In addition, the decline in real yields is also bullish for gold. Small-cap stocks, biotechnology companies and other companies with high financing needs are sensitive to interest rates, so they are expected to perform well during the interest rate cut cycle. For investors, betting on these assets through ETFs is a good choice.
Inflation cooling solidifies the expectation of Fed rate cuts! Will this industry become the new darling of Wall Street?
The SPDR S&P Biotech ETF (XBI) has achieved five consecutive gains, with a cumulative increase of nearly 8% in 5 days.